Strata Critical Medical (SRTA) Short-term Investments (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Short-term Investments data on file, last reported at $66000.0 in Q1 2026.

• Short-term Investments for Q1 2026 came in at $66000.0, down 99.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $66000.0 (down 99.92% YoY), and the FY2025 annual result was $30.3 million, down 72.17% from the prior year.
• Short-term Investments retreated to $66000.0 in Q1 2026 per SRTA's latest filing, from $30.3 million in the prior quarter.
• Over five years, Short-term Investments peaked at $266.6 million in Q1 2022 and troughed at $66000.0 in Q1 2026.
• A 5-year average of $109.3 million and a median of $115.6 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2026: Short-term Investments soared 10948.73% in 2022, then sank 99.92% in 2026.
• A 5-year view of Short-term Investments shows it stood at $150.7 million in 2022, then slipped by 8.28% to $138.3 million in 2023, then declined by 21.34% to $108.8 million in 2024, then plunged by 72.17% to $30.3 million in 2025, then sank by 99.78% to $66000.0 in 2026.
• Business Quant data shows SRTA's Short-term Investments at $66000.0 in Q1 2026, $30.3 million in Q4 2025, and $53.2 million in Q3 2025.